𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radioimmunoassay for Hepatitis B ‘e'Antigen and Antibody: Correlations with Viral Replication and Prognostic Value

✍ Scribed by M. Baraldini; A. Facchini; F. Miglio; G. Ramadori; A. Alberti; G. Realdi

Book ID
115108418
Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
470 KB
Volume
41
Category
Article
ISSN
0042-9007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of a new radioimmunoassay for
Evaluation of a new radioimmunoassay for detecting hepatitis B e antigen and its antibody
✍ Bengt Löfgren; Erik Nordenfelt 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

A new commercially available radioimmunoassay (RIA) (Abbott-HBem) was used for determination of hepatitis B e-antigen (HBeAg) and its antibody (anti-HBe). Serial serum samples from 20 transiently HBsAg-positive patients with acute hepatitis were tested. In nearly all patients HBeAg could be shown fo

Immunoglobulin M antibody to hepatitis C
Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity, and liver disease outcome
✍ Juan Antonio Quiroga; Jan van Binsbergen; Chang Yi Wang; Margarita Pardo; Sonia 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Immunoglobulin M (IgM) antibody to hepatitis C core antigen (anti-HCV-core) was tested by enzyme immunoassay against a synthetic peptide representing amino acids 1 to 62 of the core protein. Of 214 patients with different categories of histological activity, 193 ( W o ) showed positive results for I

Serum hepatitis B surface antigen and he
Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
✍ Alexander J.V. Thompson; Tin Nguyen; David Iser; Anna Ayres; Kathy Jackson; Marg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Although threshold levels for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) titers have recently been proposed to guide therapy for chronic hepatitis B (CHB), their relationship to circulating hepatitis B virus (HBV) DNA and intrahepatic HBV replicative intermediates, and the